AUPR416301A0 - Polynucleotides and polypeptides linked to neuropsychiatric di sorders - Google Patents
Polynucleotides and polypeptides linked to neuropsychiatric di sordersInfo
- Publication number
- AUPR416301A0 AUPR416301A0 AUPR4163A AUPR416301A AUPR416301A0 AU PR416301 A0 AUPR416301 A0 AU PR416301A0 AU PR4163 A AUPR4163 A AU PR4163A AU PR416301 A AUPR416301 A AU PR416301A AU PR416301 A0 AUPR416301 A0 AU PR416301A0
- Authority
- AU
- Australia
- Prior art keywords
- sorders
- neuropsychiatric
- polynucleotides
- polypeptides linked
- polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR4163A AUPR416301A0 (en) | 2001-04-02 | 2001-04-02 | Polynucleotides and polypeptides linked to neuropsychiatric di sorders |
PCT/AU2002/000424 WO2002079503A1 (en) | 2001-04-02 | 2002-04-02 | An allele of apolipoprotein e linked to neuropsychiatric disorders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR4163A AUPR416301A0 (en) | 2001-04-02 | 2001-04-02 | Polynucleotides and polypeptides linked to neuropsychiatric di sorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPR416301A0 true AUPR416301A0 (en) | 2001-05-03 |
Family
ID=3828163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPR4163A Abandoned AUPR416301A0 (en) | 2001-04-02 | 2001-04-02 | Polynucleotides and polypeptides linked to neuropsychiatric di sorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPR416301A0 (en) |
WO (1) | WO2002079503A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100248230A1 (en) * | 2007-04-14 | 2010-09-30 | Schlaak Joerg Friedrich | Novel medical diagnostic method and therapy in the context of interfreon-stimulated genes that induce depression |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6251587B1 (en) * | 1997-12-16 | 2001-06-26 | Nova Molecular, Inc. | Method for determining the prognosis of a patient with a neurological disease |
-
2001
- 2001-04-02 AU AUPR4163A patent/AUPR416301A0/en not_active Abandoned
-
2002
- 2002-04-02 WO PCT/AU2002/000424 patent/WO2002079503A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002079503A1 (en) | 2002-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AUPR497101A0 (en) | Polynucleotides and polypeptides linked to cancer and/or tumorigenesi | |
HUP0500989A2 (en) | Animicrobial polypeptides and their uses | |
AUPQ976800A0 (en) | Novel polypeptides and polynucleotides and uses therefor | |
IL153568A (en) | Novel polypeptides and polynucleotides | |
EP1409661A4 (en) | Hdac9 polypeptides and polynucleotides and uses thereof | |
EP1254266A4 (en) | Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides | |
AU2002330672A1 (en) | Gmg-1 polynucleotides and polypeptides and uses thereof | |
AU2002256276A1 (en) | Novel expansin polynucleotides, related polypeptides and methods of use | |
AU2002241899A1 (en) | Tip39 polypeptides | |
AU2002231602A1 (en) | Rank ligand-binding polypeptides | |
AU2002327676A1 (en) | Novel polynucleotides and proteins encoded thereby | |
AUPR416301A0 (en) | Polynucleotides and polypeptides linked to neuropsychiatric di sorders | |
AU2002360460A1 (en) | Methods and materials relating to novel polypeptides and polynucleotides | |
GB0112342D0 (en) | Polypeptides | |
AUPR974101A0 (en) | Novel polynucleotides and uses therefor | |
EP1365801A4 (en) | Methods and materials relating to fibulin-like polypeptides and polynucleotides | |
AU2002359351A1 (en) | Methods and materials relating to prokineticin-like polypeptides and polynucleotides | |
WO2002072611A8 (en) | Novel human egf-family proteins and polynucleotides encoding the same | |
AU2002310002A1 (en) | Ccl1 polynucleotides and polypeptides and uses thereof | |
AU2001294267A1 (en) | Survivin-like polypeptides and dnas thereof | |
AU2002251433A1 (en) | Gssp3 polynucleotides and polypeptides and uses thereof | |
AUPR402301A0 (en) | Polynucleotides and polypeptides linked to cancer and/or tumorigenesi | |
AU2003240755A1 (en) | Xcrf polynucleotides and polypeptides and uses thereof | |
AU2002227496A1 (en) | Polynucleotides and polypeptides | |
AUPQ645700A0 (en) | Novel polypeptides and polynucleotides and methods of using them |